Pharmacopeia
Salbutamol
Core pharmacology
- Chemical Pharmaceutics
Synthetic sympathomimetic amine
racemic mixture of the R- and S-isomers. The R-isomer has 150 times greater affinity for the beta2-receptor than the S-isomer and the S-isomer has been associated with toxicity
- Presentation
- Clear colourless solution containing 50-500mcg/ml after dilution for IV infusion
- Metered dose inhaler (100mcg) and dry powder (200-400mcg) for inhalation
- Clear colourless solution containing 2.5-5mg/ml for nebulization
- Oral preparation (syrup or tablets)- Mechanism of action
β2 agonist - GsPCR: Adenylate cyclase activated, cAMP
On cell membranes: ↑Na+/K+ ATPase activity and hyperpolarisation
Mild β1 agonist effects
- Physiological effects
CVS:
- At high doses, especially IV, B1 effects cause increased inotropy and chronotropy
- At lower doses, B2 effects predominate and may cause a decreased SVR due to skeletal muscle vasodilation
- May precipitate arrhythmias, particularly in the presence of hypokalaemia
Resp:
- Bronchodilation, leading to increased FEV1
- Interferes with hypoxic pulmonary vasoconstriction and may precipitate shunt leading to hypoxia
Metabolic/Other:
- Na/K/ATPase is stimulated and transports K into cells leading to hypokalaemia
- Increased blood glucose
- Beta adrenergic activity leads to increased production of lactate
- Tremor
Uterus:
- Relaxes gravid uterus
- 10% crosses the placenta and causes fetal tachycardia- Protein binding
Only weak protein binding
- Volume of distribution
Vd (IV) 4-5L/kg
- Metabolism
Converted by liver to inactive metabolite (esterified / oxidative deamination / conjugation with glucuronide)
- Excretion
Excreted urine as 40% free dug and 60% metabolite
Small amount in faeces- Half-life
T1/2 5hrs
- Special Points
Appears to potentiate NDMR
- Route And Dose
Inh/Neb/IV
- Class Group
Short-acting beta-2 adrenergic agonist bronchodilator with uterine-relaxant effects.
- Main Action
Beta-2 adrenoceptor agonism increases intracellular cAMP, producing bronchial smooth-muscle relaxation and uterine relaxation.
- Adverse Effects Toxicity
Adverse effects include tremor, palpitations or tachycardia, anxiety or insomnia, hypokalaemia, hyperglycaemia and lactic acidosis. Nausea, vomiting and postural hypotension may also occur.
- Introduction
short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD.
- Indications Uses
(i) the symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, reversible obstructive airway disease, and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor, and/or (ii) the acute prophylaxis against exercise-induced bronchospasm and other stimuli known to induce bronchospasm
- Absorption
After inhalation, about 10% of the dose reaches the bronchial tree. The remainder is swallowed and undergoes gastrointestinal absorption and first-pass metabolism.